好网站,从官网开始
企业认领/联系与合作
官网导航 提交官网
A

Ainnocence官网

我们的平台使用 AI 来帮助您加快药物发现过程。我们可以一起做出很大的改变

官网资料

网站名称
Ainnocence
所属分类
AI办公效率
身份核实
尚未完成企业认领核实
最近更新
链接检测
尚未检测

关于 Ainnocence

Ainnocence · AI-Native Antibody & Molecule Discovery Platform Pipeline Team News Resources Book a call AI-Native Drug Discovery Design without structure. Screen against everything. Ainnocence designs binders from sequence alone — no crystal structure, no docking, no predicted-fold error to inherit. The same property lets us do what structure-based pipelines cannot: score every candidate against the surface and circulating human proteome for antibodies, and the full proteome for small molecules, before a single molecule is made. Specificity becomes a design constraint, not a late-stage surprise. Explore the platform → Partner with us 15 /40 Validated targets with sub-nM leads 6 Single-digit picomolar campaigns 2,872 Molecules experimentally tested in wet lab 167 M Parameter protein foundation model (AINN-P1) Our Mission We are rebuilding drug discovery from the sequence up, making therapeutic design computational, honest, and partner-ready. Most AI drug-discovery platforms stop at a demo. We go further: our models are trained on industry-grade proprietary data and validated at every stage by wet-lab experiments, so what we deliver to pharma partners is already de-risked. The result is a different kind of handoff, not a screening score, but a program: patentable, validated, licensable, and ready for your development pipeline. Sequence-first design Protein foundation model, no 3D structure required Wet-lab validated Every lead confirmed experimentally Patentable IP Clean freedom-to-operate on novel compositions Licensed to partners Programs ready for pharma development Platform SentinusAI®, a protein foundation model that produces binders, not scores. Built on AINN-P1, SentinusAI combines sequence modeling, affinity prediction, and generative design into a single pipeline. Trained on proprietary assay data and continuously benchmarked against wet-lab outcomes. 01 · Antibody De novo & affinity maturation IgG, Fab, scFv, VHH, bispecifics. Picomolar leads on IL-13, IL-25, IL-36R, TSLP. Sub-nM · 15/40 targets 02 · Small molecule CarbonAI, generative chemistry De novo small molecules, PROTAC design, scaffold hopping. CRBN neosubstrate selectivity panels. 10 10 virtual · overnight 03 · Peptide PeptideAI, cyclic & stapled GLP-1 analogs, cyclic peptides, stapled therapeutics. 3.2M-peptide screens with 90%+ accuracy. 3.2M screens 04 · Cell therapy CellulaAI, CAR-T engineering CAR construct optimization, activation prediction, persistence modeling. Preclinical validate

访问提示

本站仅提供官网信息与访问导航,不代表对该网站的产品、服务或交易作出担保。访问外部网站时,请核对网址,注意账号和财产安全。

同类型网站 580

查看分类

AI音视频转图文、总结、思维导图与翻译工具。AI好记融合了DeepSeek大模型,能够将音视频内容快速转化为文字,并生成翻译、总结以及思维导图等,帮助用户高效地处理和吸收信息。

AI神农大脑可能具备智能交互功能,能够根据用户的问题和需求提供相应的回答和解决方案,帮助用户更高效地获取信息和解决问题.

ApacheMXNet 是一个真正的开源深度学习框架,适用于灵活的研究原型设计和生产应用,支持从原型到大规模部署的深度学习解决方案。

让更多人找到你的官网

提交网站信息,建立清晰、完整的官网资料。

免费提交官网

咨询提交、推广、认领

客服微信二维码,长按识别或保存后使用微信扫一扫

扫一扫添加微信,沟通官网导航提交、认领、推广需求。

可长按识别,或保存图片后在微信扫一扫中识别。

添加时可备注“官网导航”,便于沟通您的企业需求。

保存二维码 打开原图